Valeant Shares Fall As Ackman Exit Highlights Company’s Challenges
Valeant Pharmaceuticals Inc’s stock price fell to its lowest level in eight years on Tuesday after the abrupt exit of its biggest supporter put renewed focus on the Canadian company’s most pressing problem: raising capital to cut its roughly $30 billion debt pile. Billionaire investor William Ackman spent more than a year trying to revive … Read more